Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism GR antagonists(Glucocorticoid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Phase 1 | United States | - | |
Neurodegenerative Diseases | Phase 1 | United States | - | |
Obesity | Phase 1 | United States | - | |
Pituitary ACTH Hypersecretion | Phase 1 | United States | - | |
Diabetes Mellitus, Type 1 | Preclinical | United States | 08 Jul 2002 |